Paclitaxel-Eluting versus Sirolimus-Eluting Stents in Diabetes Mellitus: A Report from the NHLBI Dynamic Registry

BACKGROUND: Diabetes is a powerful predictor of adverse events in patients undergoing percutaneous coronary intervention. Drug-eluting stents (DES) reduce restenosis rates compared to bare metal stents, however controversy remains regarding which DES provides greater benefit in patients with diabete...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wolf, William M., Vlachos, Helen A., Marroquin, Oscar C., Lee, Joon S., Smith, Conrad, Anderson, William D., Schindler, John T., Holper, Elizabeth M., Dawn Abbott, J., Williams, David O., Laskey, Warren K., Kip, Kevin E., Kelsey, Sheryl F., Mulukutla, Suresh R.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947208/
https://ncbi.nlm.nih.gov/pubmed/20118153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.109.885996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars